49
BioTOPics 47 | May 2014
BioTOP-Report
Addresses
Biotech Companies
Biotech-Laboratorium für
Environment BLE GmbH
Development of detection systems which are able, economically and rapidaly, to detect
oil contaminations and industrial oil waste, in soil and in water and their biological de-
pletion. The BLE GmbH is concerned with the biological degradation of oil contamina-
tions and the development of a set of bio-preparations consisting of different bacterial
strains which break down oil.
mobiclup.de
biotechrabbit GmbH
biotechrabbit GmbH is determined to offer the newest and best life science products
and innovative solutions to scientists leading the fight againstdisease and fueling our
lives with innovations. We supply ultra pure enzymes and high-quality antibody ser-
vices for diagnostics and a life science product portfolio(including reagents for PCR
and nucleic acid purification)for molecular biology and proteomics. The biotechrabbit
advantage is our combination ofpassion for excellent research with the agility of true
entrepreneurship.
biotechrabbit.com
BIOTECON Diagnostics GmbH
BIOTECON Diagnostics has been well known as a qualified partner in the field of mo-
lecular and microbiology for the last 13 years. We focus on development, production
and marketing of PCR-based rapid detection systems. BIOTECON Diagnostics offers
solutions for the food and beverage industry as well as for producers of pharmaceuti-
cals and cosmetics.
bc-diagnostics.com
BioTeZ Berlin-Buch GmbH
Services (Custom DNA and RNA Oligonucleotide synthesis, Immuno affinity columns)
- Development of Enzyme Immunoassays, e.g. for Therapeutic Antibodies- Bio Conju-
gates - Immobilization of Bio Molekules for better Signalling-R&D (Aptamer).
biotez.de
BIOWORX -Biotechnologielabor-
Thomas Grimm
BIOWORX offers services in the fields of contract research for customer-specific Bio-
transformations, the screening, isolation and production of Biocatalysts from microor-
ganisms and plants and the bioanalytic syntheses. Further organic compounds and
metabolites will be synthesized with enzymes for customer in kg scale.
bioworx.de
BiRDS Pharma GmbH
BiRDS Pharma GmbH, integrated into the BDD/CCDRD group, provides services in the
field of drug development to pharmaceutical and biotech companies, including man-
agement of drug development projects as well as consulting services. The company
also pursues own drug development projects based on intellectual property generated
within BDD/CCDRD group, with a focus on drug candidates derived from Atomic Sub-
stitution Technology (AST).
birdspharma.com
Blue Biolabs GmbH
Blue Biolabs is a spin-off company from the TU-Berlin, which specialises in the devel-
opment of products and services in the field of environmental analysis using methods
of microbiology and molecular biology.
bluebiolabs.de
Botiss medical AG
Botiss biomaterials is a privately owned biotech company, headquartered in Berlin.
botiss is the leading German specialist for dental bone and tissue regeneration (BTR).
We focus on the development of innovative regenerative materials and clinical market-
ing / distribution in over 50 countries world-wide. The botiss subsidiary Cell+Tissue
Bank Austria is a leading European manufacturer of allogenic materials for hard tissue
regeneration.
botiss.com
BST Bio Sensor Technology
GmbH
BST develops and produces biosensors to provide high quality analysis at moderate
prices. In 1982 BST brought on the market the first multi-way biosensor based blood
glucose analyzer in Europe and is since then market leader in Europe. Today BST sells
more than 60.000 sensors a year. Since 2008 BST is besides biosensors also manufac-
turer of POCT and laboratory instruments.
bst-biosensor.de
Caprotec bioanalytics GmbH
Caprotecs Capture Compound Mass Spectrometry (CCMS) Technology allows sepa-
ration and isolation of proteins based on functionality. For many applications, CCMS is
clearly superior to conventional methods - thus addressing an unmet need in the pro-
teomics research community. The company is commercializing the CCMS technology
through ImproMed projects with pharmaceutical and biotechnology companies. The
focus on these collaborations is on investigating mechanisms of drug action (MoA)
and identification of on- and off-target proteins to understand potential adverse effects
of drug candidates on a molecular level. This can be easily carried out in the lead
optimization process, or even earlier to increase the probability of success later on in
the clinic.
caprotec.com
Capsulution Pharma AG
Capsulution Pharma AG develops innovative nano- and micron-sized capsules. The
company applies its worldwide-patented so-called LBL-Technology
®
. Based on their
minute size, their functionality and their highly reproducible production process the
capsules can be used for a multitude of different applications. Accordingly, the precise-
ly sized capsules (500 nm to 50 µm) can be made to function in a manner to suit the
intended application, and can be given the appropriate biochemical, electrical, optical
and magnetic properties as required by the customer.
capsulution.com
Celares GmbH
Specialist for Drug Delivery of peptides/proteins by using PEGylation. Modification of
Biopharmaceuticals with polyethylene glycol in order to substantially improve phar-
macological properties. Offers the unique CelaSYS-PEGylation technology, which is
patented by celares. CelaSYS: non-dispersed, highly branched polyethylene glycol
based reagents. Additionally celares offers customized PEGylation solutions as well as
synthesis of customized PEG-reagents.
celares.com
Cell Medica GmbH
Cell Medica develops, manufactures and markets personalized cellular immunothera-
peutics for infectious disease and cancer.
cellmedica.co.uk